Cargando…

Antitumor Activity of Ad-IU2, a Prostate-Specific Replication-Competent Adenovirus Encoding the Apoptosis Inducer, TRAIL

In this study, we investigated the preclinical utility and antitumor efficacy of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) delivered by Ad-IU2, a prostate-specific replication-competent adenovirus (PSRCA), against androgen-independent prostate cancer. Through transcriptional co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiménez, Juan Antonio, Li, Xiong, Zhang, Yan-Ping, Bae, Kyung Hee, Mohammadi, Yousef, Pandya, Pankita, Kao, Chinghai, Gardner, Thomas A.
Formato:	Texto
Lenguaje:	English
Publicado:	2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821463/ https://www.ncbi.nlm.nih.gov/pubmed/19798123 http://dx.doi.org/10.1038/cgt.2009.62

Ejemplares similares

Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells
por: Liu, Youhong, et al.
Publicado: (2014)

Antitumor Activity of TRAIL Recombinant Adenovirus in Human Malignant Glioma Cells
por: Kim, Ki-Uk, et al.
Publicado: (2005)

Generation and Characterization of a Replication-Competent Human Adenovirus Type 55 Encoding EGFP
por: Li, Wei, et al.
Publicado: (2023)

No more helper adenovirus: production of gutless adenovirus (GLAd) free of adenovirus and replication-competent adenovirus (RCA) contaminants
por: Lee, Dongwoo, et al.
Publicado: (2019)

Engineered adenovirus fiber shaft fusion homotrimer of soluble TRAIL with enhanced stability and antitumor activity
por: Yan, J, et al.
Publicado: (2016)

Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia
por: Wang, Zixuan, et al.
Publicado: (2020)

Development of replication-competent adenovirus based vaccine vectors
por: Abbink, P, et al.
Publicado: (2012)

300 IU vs. 200 IU of OnabotulinumtoxinA for detrusor overactivity
por: Persu, Cristian
Publicado: (2014)

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization
por: Maxfield, Lori F., et al.
Publicado: (2015)

Cardiac Murmurs Iu Chorea
Publicado: (1871)

Synergistic antitumor effects of CDK inhibitor SNS-032 and an oncolytic adenovirus co-expressing TRAIL and Smac in pancreatic cancer
por: Ge, Yun, et al.
Publicado: (2017)

Vitamin D(3) Supplementation: Comparison of 1000 IU and 2000 IU Dose in Healthy Individuals
por: Dědečková, Eva, et al.
Publicado: (2023)

No effect of monthly supplementation with 12000 IU, 24000 IU or 48000 IU vitamin D3 for one year on muscle function: The vitamin D in older people study
por: Ranathunga, R.M.T.K., et al.
Publicado: (2019)

Transgene Expression and Host Cell Responses to Replication-Defective, Single-Cycle, and Replication-Competent Adenovirus Vectors
por: Crosby, Catherine M., et al.
Publicado: (2017)

IU professor contributes to particle accelerator
Publicado: (2008)

An added dimension to tumour TRAIL sensitivity
por: Healy, Sandra, et al.
Publicado: (2015)

FMDV replicons encoding green fluorescent protein are replication competent
por: Tulloch, Fiona, et al.
Publicado: (2014)

Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma
por: Jiang, Yuanyuan, et al.
Publicado: (2016)

Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancer
por: Nelson, Amy R, et al.
Publicado: (2009)

Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells
por: Li, Li-xia, et al.
Publicado: (2013)

A Randomized Control Trial of 3 IU IV Oxytocin Bolus with 7 IU Oxytocin Infusion versus 10 IU Oxytocin Infusion During Cesarean Section for Prevention of Postpartum Hemorrhage
por: Yaliwal, Rajasri G, et al.
Publicado: (2020)

Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in critically ill patients and 5,000 IU in medical patients: a prospective randomized study
por: Heinz, GH, et al.
Publicado: (2013)

Development of replication-competent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoter
por: Seo, Ho Kyung, et al.
Publicado: (2014)

IU physicists help unlock universe's secrets
Publicado: (2003)

Eradication of Metastatic Renal Cell Carcinoma after Adenovirus-Encoded TNF-Related Apoptosis-Inducing Ligand (TRAIL)/CpG Immunotherapy
por: Norian, Lyse A., et al.
Publicado: (2012)

What is the feasibility of switching to 200IU OnabotulinumtoxinA in patients with detrusor overactivity who have previously received 300IU?
por: Malki, Manar, et al.
Publicado: (2014)

Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D(3)
por: Schoenmakers, Inez, et al.
Publicado: (2013)

Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma
por: Hai, Cui, et al.
Publicado: (2012)

Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression
por: Yang, Shan, et al.
Publicado: (2015)

Rapid Construction of a Replication-Competent Infectious Clone of Human Adenovirus Type 14 by Gibson Assembly
por: Pan, Haibin, et al.
Publicado: (2018)

Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer
por: D’Alise, Anna Morena, et al.
Publicado: (2023)

Adenovirus-Encoding Virus-Associated RNAs Suppress HDGF Gene Expression to Support Efficient Viral Replication
por: Kondo, Saki, et al.
Publicado: (2014)

Activation of systemic antitumor immunity via TRAIL-induced apoptosis
por: James, Britnie R., et al.
Publicado: (2012)

Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter
por: Hamada, Katsuyuki, et al.
Publicado: (2014)

Synergistic antitumoral efficacy of a novel replicative adenovirus SG611-PDCD5 and daunorubicin in human leukemic cells
por: Zhou, Ya-Lan, et al.
Publicado: (2018)

Improving the Transduction Efficiency and Antitumor Effect of Conditionally Replicative Adenovirus by Application of 6-Cyclohexyl Methyl-β-D-maltoside
por: Lu, Wenjing, et al.
Publicado: (2023)

Intratumoral delivery of a novel oncolytic adenovirus encoding human antibody against PD-1 elicits enhanced antitumor efficacy
por: Zhou, Ping, et al.
Publicado: (2022)

Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model
por: El-Shemi, Adel Galal, et al.
Publicado: (2016)

Antiviral Effects of Curcumin on Adenovirus Replication
por: Jennings, Morgan R., et al.
Publicado: (2020)

Efficacy and Safety of 90,000 IU versus 300,000 IU Single Dose Oral Vitamin D in Nutritional Rickets: A Randomized Controlled Trial
por: Mittal, Medha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_alp8vekdhlcckdqvic3qjfs7kr